MedTrace Logo

Patient Engagement Study to Evaluate the Use of Biological Therapies for Cardiac Arrhythmias

NCT05032495 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2024-04-09

No results posted yet for this study

Summary

In this patient engagement study, patients and partners will attend a presentation, group meeting and responding to the survey to help the research team gage the acceptability of using a biological therapy to prevent cardiac arrhythmia. Patient Partners will also help to clarify which outcomes are important to patients, to ensure the selected outcomes align with patient interests.

Conditions

  • Arrythmia

Interventions

OTHER

Surveys

Surveys to evaluate prior experience, opinions and intervention acceptability.

OTHER

Focus group

To answer any questions and discuss topics covered in the standard presentation.

Sponsors & Collaborators

  • Ottawa Heart Institute Research Corporation

    lead OTHER

Principal Investigators

  • Darryl Davis · Ottawa Heart Institute Research Corporation

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2023-08-31
Completion
2023-08-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05032495 on ClinicalTrials.gov